Osteoporosis — progressive loss of bone density leading to fragile bones — affects an estimated 1 in 3 South African women and 1 in 5 men over 50. Despite its enormous burden (hip fractures are associated with up to 20% mortality within one year in older patients), osteoporosis is substantially underdiagnosed and undertreated. From a medical aid perspective, osteoporosis is not a CDL or PMB condition as a standalone chronic disease — but fragility fractures, when they occur, are PMB-covered surgical emergencies. Understanding this distinction shapes the entire cost picture.
What Is Osteoporosis?
Bone is living tissue that is continuously broken down and rebuilt. Osteoporosis occurs when bone resorption exceeds bone formation, causing bones to become porous and fragile. The condition is "silent" — it causes no symptoms until a fracture occurs.
Osteopenia: T-score −1.0 to −2.5 (bone density lower than normal but not yet osteoporotic) Osteoporosis: T-score ≤ −2.5 (confirmed on DEXA scan) Severe osteoporosis: T-score ≤ −2.5 + existing fragility fracture
Key fracture sites: - Hip (femoral neck/trochanter) — most serious; high mortality - Spine (vertebral compression fractures) — often painless until sudden collapse - Wrist (Colles fracture) — typical after a fall on outstretched hand - Shoulder (proximal humerus)
Who Is at Risk in South Africa?
Osteoporosis is particularly prevalent in: - Post-menopausal women (oestrogen loss accelerates bone loss after menopause) — all women over 50 should consider DEXA screening - Men over 65 (testosterone decline contributes; often undertreated) - Patients on long-term corticosteroids (for RA, asthma, IBD, transplant) — glucocorticoid-induced osteoporosis is distinct and often undertreated - Patients with inflammatory arthritis (RA, AS, IBD) — inflammation drives bone loss - HIV-positive patients (HIV and antiretroviral therapy — particularly tenofovir — affect bone density) - Low BMI — thinness is a risk factor for osteoporosis - Current smokers and heavy alcohol users
Is Osteoporosis a PMB or CDL Condition?
Osteoporosis is not on the CDL and is not a standard PMB Diagnosis and Treatment Pair as a chronic condition.
All costs for osteoporosis prevention and chronic management — DEXA scanning, medication, monitoring — come from your day-to-day benefit, MSA, or ATB.
Critical exception: When osteoporosis causes a fragility fracture requiring surgical intervention (hip replacement, spinal surgery, vertebral augmentation), the fracture and its treatment IS PMB-covered under the relevant orthopaedic or trauma DTP.
How Does Medical Aid Cover Osteoporosis?
| Service | PMB/CDL? | Typical cover | Notes |
|---|---|---|---|
| GP consultation | No | Day-to-day | |
| DEXA scan (bone density) | No | Radiology benefit — varies | Some plans cover 1 DEXA every 2 years; others not at all — check your benefit |
| Blood tests (calcium, vitamin D, PTH, renal function) | No | Pathology benefit | Standard annual monitoring |
| Calcium carbonate (1,000–1,200mg/day) | No | OOP — inexpensive | R50–R150/month; OTC available |
| Vitamin D3 (800–2,000 IU/day) | No | OOP — inexpensive | R30–R80/month; OTC available |
| Alendronate (weekly oral bisphosphonate — first-line) | No | Day-to-day | Generic: R80–R200/month; very cost-effective |
| Risedronate (alternative bisphosphonate) | No | Day-to-day | R100–R250/month |
| Zoledronic acid (annual IV infusion) | No | Day procedure benefit | R2,000–R5,000 per annual infusion; convenient once-a-year |
| Denosumab (Prolia 60mg injection 6-monthly) | No | Day-to-day — check formulary | R3,000–R4,500 per 6-monthly injection = R6,000–R9,000/year |
| Romosozumab (Evenity — newer, high-risk patients) | No | Day-to-day — check formulary | R5,000–R8,000/month; 12-month course; not widely covered |
| Hip fracture surgery (hemiarthroplasty/THR) | Yes — PMB (trauma/orthopaedic DTP) | Hospital benefit (PMB) | Fragility fracture = PMB event |
| Vertebral augmentation (kyphoplasty/vertebroplasty) | Partial — PMB if acute event | Hospital benefit | For acute painful vertebral compression fractures |
| Post-fracture rehabilitation (physio, OT) | No | Day-to-day — limited | Critical for recovery; limited funding |
DEXA Scan Coverage — Check Your Plan
DEXA scan is the diagnostic standard for osteoporosis. Scheme coverage varies significantly:
- Some plans cover 1 DEXA scan per 2 years as a preventive/screening benefit
- Others require clinical indication (prior fracture, high-risk patient on corticosteroids)
- Cost if OOP: R1,500–R3,500 at private radiology centres
Ask your scheme: "Is DEXA bone density scanning covered under my plan, and under which benefit — radiology, wellness, or preventive?"
Who should have a DEXA in SA (recommended): - All women ≥ 65 years - Women 50–64 with risk factors (family history, low BMI, corticosteroid use, prior fracture) - Men ≥ 70 years - Any patient on long-term corticosteroids (>3 months) - Patients with inflammatory arthritis, HIV, or other conditions affecting bone
Day-to-Day Costs: What to Budget For
| Scenario | Estimated annual cost |
|---|---|
| Prevention — calcium + vitamin D + annual GP | R3,000 – R8,000 |
| Mild osteoporosis, generic alendronate + annual DEXA + GP | R8,000 – R18,000 |
| Moderate osteoporosis on denosumab + monitoring | R18,000 – R30,000 |
| Post-fracture: surgery (PMB) + rehabilitation (OOP) | R15,000–R40,000 for rehab OOP |
Generic alendronate is one of the most cost-effective medications in medicine — proven to reduce fracture risk by 50% at a cost of R80–R200/month. Starting treatment early and using generic bisphosphonates makes osteoporosis one of the most cost-effective conditions to manage.
Key Questions to Ask Your Scheme
- Is DEXA scanning covered under my plan? Ask specifically — and ask how often.
- Are bisphosphonates (alendronate/risedronate) on my formulary? They should be — generic is widely available.
- Is denosumab (Prolia) on my formulary, and is it covered under my chronic medication benefit? For patients who cannot tolerate bisphosphonates.
- If I am on long-term corticosteroids, does my plan have a glucocorticoid-induced osteoporosis (GIOP) programme? Some schemes recognise this as a higher-risk category.
Talk to Eldon
Osteoporosis prevention is extremely cost-effective — the cost of prevention (alendronate at R80–R200/month) is a fraction of the cost of a hip fracture. The Check shows what each plan on our panel pays for this, side by side, and Eldon advises from there.
See which plans pay for osteoporosis management →